Cargando…
Successful Treatment of Symptomatic Epilepsy with Oral Valproic Acid and Levetiracetam in a Patient with Short-bowel Syndrome
Valproic acid (VPA) and levetiracetam (LEV) are used in epilepsy treatment. However, their use to treat short-bowel syndrome has not been reported. We herein report a 68-year-old man who was hospitalized for symptomatic epilepsy following cerebral infarction. He had a history of superior mesenteric...
Autores principales: | Kurishima, Akira, Hayashi, Mototaka, Shimozato, Rin, Isozaki, Ryo, Shioda, Tomoko, Iijima, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152876/ https://www.ncbi.nlm.nih.gov/pubmed/34670882 http://dx.doi.org/10.2169/internalmedicine.7622-21 |
Ejemplares similares
-
Treatment Strategies for Basilar Top Syndrome Caused by Acute Vertebral Artery Occlusion
por: Kojima, Iori, et al.
Publicado: (2020) -
In-Stent Restenosis of Carotid and Vertebral Arteries Treated by Angioplasty Using a Cutting Balloon: A Case Report
por: Shimozato, Rin, et al.
Publicado: (2021) -
First‐line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid
por: van der Meer, Pim B., et al.
Publicado: (2021) -
Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014) -
Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature
por: Kuo, Cheng-Yen, et al.
Publicado: (2020)